[Skip to Content]
[Skip to Content Landing]
October 21, 2009

Corticosteroid Therapy for Severe Sepsis and Septic Shock

JAMA. 2009;302(15):1643-1645. doi:10.1001/jama.2009.1480

To the Editor: The systematic review by Dr Annane and colleagues1 summarized the results of 22 clinical trials investigating corticosteroid therapy in sepsis. The review suggested that prolonged low-dose corticosteroid therapy (≥5 days, ≤300 mg/d of hydrocortisone or equivalent) decreases mortality and recommended treating adult patients with vasopressor-dependent septic shock. However, we believe that these recommendations are weakened by possible publication bias and by the relationship between severity of illness and the treatment effect of corticosteroids.

First Page Preview View Large
First page PDF preview
First page PDF preview